Citations (86)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Gabor Xantus, Laszlo Zavori, Candice Matheson, V. Anna Gyarmathy, Laszlo M Fazekas & Peter Kanizsai. (2021) Cannabidiol in low back pain: scientific rationale for clinical trials in low back pain. Expert Review of Clinical Pharmacology 14:6, pages 671-675.
Read now
Read now
Praveen PN Rao & Tarek Mohamed. (2011) Current and emerging “at-site” pain medications: a review. Journal of Pain Research 4, pages 279-286.
Read now
Read now
David R Janero & Alexandros Makriyannis. (2009) Cannabinoid receptor antagonists: pharmacological opportunities, clinical experience, and translational prognosis. Expert Opinion on Emerging Drugs 14:1, pages 43-65.
Read now
Read now
Wayne E Childers, Adam M Gilbert, Jeffrey D Kennedy & Garth T Whiteside. (2008) Advances in the development of novel analgesics. Expert Opinion on Therapeutic Patents 18:9, pages 1027-1067.
Read now
Read now
Simon J Read & Andy Dray. (2008) Osteoarthritic pain: a review of current, theoretical and emerging therapeutics. Expert Opinion on Investigational Drugs 17:5, pages 619-640.
Read now
Read now
William John Redmond, Philippe Goffaux, Stéphane Potvin & Serge Marchand. (2008) Analgesic and antihyperalgesic effects of nabilone on experimental heat pain. Current Medical Research and Opinion 24:4, pages 1017-1024.
Read now
Read now
Fabian Docagne, Leyre Mestre, Frida Loría, Miriam Hernangómez, Fernando Correa & Carmen Guaza. (2008) Therapeutic potential of CB2 targeting in multiple sclerosis. Expert Opinion on Therapeutic Targets 12:2, pages 185-195.
Read now
Read now
Articles from other publishers (79)
Diana Persia, Francesca Mangiavacchi, Maria Carla Marcotullio & Ornelio Rosati. (2023) Cannabinoids as multifaceted compounds. Phytochemistry 212, pages 113718.
Crossref
Crossref
Ankush Kumar, Ojasvi Gupta, Rohit Bhatia & VikramDeep Monga. (2023) Impact of Cannabinoid Receptors in the Design of Therapeutic Agents
against Human Ailments. Current Topics in Medicinal Chemistry 23:19, pages 1807-1834.
Crossref
Crossref
Giovanni Graziano, Pietro Delre, Francesca Carofiglio, Josè Brea, Alessia Ligresti, Magdalena Kostrzewa, Chiara Riganti, Claudia Gioè-Gallo, Maria Majellaro, Orazio Nicolotti, Nicola Antonio Colabufo, Carmen Abate, Maria Isabel Loza, Eddy Sotelo, Giuseppe Felice Mangiatordi, Marialessandra Contino, Angela Stefanachi & Francesco Leonetti. (2023) N-adamantyl-anthranil amide derivatives: New selective ligands for the cannabinoid receptor subtype 2 (CB2R). European Journal of Medicinal Chemistry 248, pages 115109.
Crossref
Crossref
Sarah Allam, Elizabeth Paris, Itzel Lazcano, Pincas Bitterman, Sanjib Basu, James O’Donnell & Animesh Barua. (2022) Detection of Cannabinoid Receptor Expression by Endometriotic Lesions in Women with Endometriosis as an Alternative to Opioid-Based Pain Medication. Journal of Immunology Research 2022, pages 1-9.
Crossref
Crossref
María Salud García-Gutiérrez, Francisco Navarrete, Ani Gasparyan, Daniela Navarro, Álvaro Morcuende, Teresa Femenía & Jorge Manzanares. (2022) Role of Cannabinoid CB2 Receptor in Alcohol Use Disorders: From Animal to Human Studies. International Journal of Molecular Sciences 23:11, pages 5908.
Crossref
Crossref
Camila Pantoja-Ruiz, Paula Restrepo-Jimenez, Camilo Castañeda-Cardona, Alexandra Ferreirós & Diego Rosselli. (2022) Cannabis and pain: a scoping review. Brazilian Journal of Anesthesiology (English Edition) 72:1, pages 142-151.
Crossref
Crossref
Zhiguo Wang & Baofeng YangZhiguo Wang & Baofeng Yang. 2022. Polypharmacology. Polypharmacology
375
396
.
Ravichandran Veerasamy, Anitha Roy, Rohini Karunakaran & Harish Rajak. (2021) Structure–Activity Relationship Analysis of Benzimidazoles as Emerging Anti-Inflammatory Agents: An Overview. Pharmaceuticals 14:7, pages 663.
Crossref
Crossref
Harvey F. Fulo, Amal Shoeib, Christian V. Cabanlong, Alexander H. Williams, Chang-Guo Zhan, Paul L. Prather & Gregory B. Dudley. (2021) Synthesis, Molecular Pharmacology, and Structure–Activity Relationships of 3-(Indanoyl)indoles as Selective Cannabinoid Type 2 Receptor Antagonists. Journal of Medicinal Chemistry 64:9, pages 6381-6396.
Crossref
Crossref
Md Afjalus Siraj, Md. Rahman, Ghee Tan & Veronique Seidel. (2021) Molecular Docking and Molecular Dynamics Simulation Studies of Triterpenes from Vernonia patula with the Cannabinoid Type 1 Receptor. International Journal of Molecular Sciences 22:7, pages 3595.
Crossref
Crossref
Catharine A. Mielnik, Vincent M. Lam & Ruth A. Ross. (2021) CB1 allosteric modulators and their therapeutic potential in CNS disorders. Progress in Neuro-Psychopharmacology and Biological Psychiatry 106, pages 110163.
Crossref
Crossref
Md Afjalus Siraj, Md Sariful Islam Howlader, Md Sohanur Rahaman, Jamil A. Shilpi & Veronique Seidel. (2020)
Antinociceptive and sedative activity of
Vernonia patula
and predictive interactions of its phenolic compounds with the cannabinoid type 1 receptor
. Phytotherapy Research 35:2, pages 1069-1079.
Crossref
Crossref
Bei-Er Jiang, Xingwu Jiang, Qiansen Zhang, Qiuwen Liang, Zi-Liang Qiu, Xiang-Bai Sun, Jun-Jie Yang, Si Chen, Chunyang Yi, Xiaolei Chai, Mingyao Liu, Li-Fang Yu, Weiqiang Lu & Han-Kun Zhang. (2020) From a Designer Drug to the Discovery of Selective Cannabinoid Type 2 Receptor Agonists with Favorable Pharmacokinetic Profiles for the Treatment of Systemic Sclerosis. Journal of Medicinal Chemistry 64:1, pages 385-403.
Crossref
Crossref
Robert S. Ackerman, Frederick Li, Tom Mario Davis & Nathaniel Loo. 2020. Pain Management for Clinicians. Pain Management for Clinicians
141
174
.
Samuel D. Banister, Kaavya Krishna Kumar, Vineet Kumar, Brian K. Kobilka & Sanjay V. Malhotra. (2019)
Selective modulation of the cannabinoid type 1 (CB
1
) receptor as an emerging platform for the treatment of neuropathic pain
. MedChemComm 10:5, pages 647-659.
Crossref
Crossref
Chuang Zhao, K.P. Rakesh, L. Ravidar, Wan-Yin Fang & Hua-Li Qin. (2019) Pharmaceutical and medicinal significance of sulfur (SVI)-Containing motifs for drug discovery: A critical review. European Journal of Medicinal Chemistry 162, pages 679-734.
Crossref
Crossref
Natascia Bruni, Carlo Della Pepa, Simonetta Oliaro-Bosso, Enrica Pessione, Daniela Gastaldi & Franco Dosio. (2018) Cannabinoid Delivery Systems for Pain and Inflammation Treatment. Molecules 23:10, pages 2478.
Crossref
Crossref
Sang Won Jung, Art E. Cho & Wookyung Yu. (2018) Exploring the Ligand Efficacy of Cannabinoid Receptor 1 (CB1) using Molecular Dynamics Simulations. Scientific Reports 8:1.
Crossref
Crossref
M.A. Fitzcharles & E. Eisenberg. (2018) Medical cannabis: A forward vision for the clinician. European Journal of Pain 22:3, pages 485-491.
Crossref
Crossref
J. Lötsch, I. Weyer-Menkhoff & I. Tegeder. (2018) Current evidence of cannabinoid-based analgesia obtained in preclinical and human experimental settings. European Journal of Pain 22:3, pages 471-484.
Crossref
Crossref
Jijun Xu, Yuying Tang, Mian Xie, Bihua Bie, Jiang Wu, Hui Yang, Joseph F. Foss, Bin Yang, Richard W. Rosenquist & Mohamed Naguib. (2016) Activation of cannabinoid receptor 2 attenuates mechanical allodynia and neuroinflammatory responses in a chronic post-ischemic pain model of complex regional pain syndrome type I in rats. European Journal of Neuroscience 44:12, pages 3046-3055.
Crossref
Crossref
Zebing Huang, Haiyan Wang, Jingke Wang, Mengqin Zhao, Nana Sun, Fangfang Sun, Jianxin Shen, Haiying Zhang, Kunkun Xia, Dejie Chen, Ming Gao, Ronald P. Hammer, Qingrong Liu, Zhengxiong Xi, Xuegong Fan & Jie Wu. (2016) Cannabinoid receptor subtype 2 (CB2R) agonist, GW405833 reduces agonist-induced Ca2+ oscillations in mouse pancreatic acinar cells. Scientific Reports 6:1.
Crossref
Crossref
D. S. Reddy & V. M. Golub. (2016) The Pharmacological Basis of Cannabis Therapy for Epilepsy. Journal of Pharmacology and Experimental Therapeutics 357:1, pages 45-55.
Crossref
Crossref
Ruben Vardanyan & Victor Hruby. 2016. Synthesis of Best-Seller Drugs. Synthesis of Best-Seller Drugs
15
64
.
Qing Li, Qinghua Hu, Xinning Wang, Yang Zong, Leilei Zhao, Junhao Xing, Jinpei Zhou & Huibin Zhang. (2015) Discovery of Novel 2-(piperidin-4-yl)-1H-benzo[d]imidazole Derivatives as Potential Anti-Inflammatory Agents. Chemical Biology & Drug Design 86:4, pages 509-516.
Crossref
Crossref
Shuang Han, Fei-Fei Zhang, Hai-Yan Qian, Li-Li Chen, Jian-Bin Pu, Xin Xie & Jian-Zhong Chen. (2015)
Development of Quinoline-2,4(1
H
,3
H
)-diones as Potent and Selective Ligands of the Cannabinoid Type 2 Receptor
. Journal of Medicinal Chemistry 58:15, pages 5751-5769.
Crossref
Crossref
Roman O. Iakovenko, Anna N. Kazakova, Vasiliy M. Muzalevskiy, Alexander Yu. Ivanov, Irina A. Boyarskaya, Andrea Chicca, Vanessa Petrucci, Jürg Gertsch, Mikhail Krasavin, Galina L. Starova, Andrey A. Zolotarev, Margarita S. Avdontceva, Valentine G. Nenajdenko & Aleksander V. Vasilyev. (2015)
Reactions of CF
3
-enones with arenes under superelectrophilic activation: a pathway to trans-1,3-diaryl-1-CF
3
-indanes, new cannabinoid receptor ligands
. Organic & Biomolecular Chemistry 13:33, pages 8827-8842.
Crossref
Crossref
N A Balenga, E Martínez-Pinilla, J Kargl, R Schröder, M Peinhaupt, W Platzer, Z Bálint, M Zamarbide, I G Dopeso-Reyes, A Ricobaraza, J M Pérez-Ortiz, E Kostenis, M Waldhoer, A Heinemann & R Franco. (2014)
Heteromerization of GPR55 and cannabinoid CB
2
receptors modulates signalling
. British Journal of Pharmacology 171:23, pages 5387-5406.
Crossref
Crossref
Sarah Rosenthaler, Birgit P?hn, Caroline Kolmanz, Chi Nguyen Huu, Christopher Krewenka, Alexandra Huber, Barbara Kranner, Wolf-Dieter Rausch & Rudolf Moldzio. (2014) Differences in receptor binding affinity of several phytocannabinoids do not explain their effects on neural cell cultures. Neurotoxicology and Teratology 46, pages 49-56.
Crossref
Crossref
Giovanni Pinna, Giovanni Loriga, Paolo Lazzari, Stefania Ruiu, Matteo Falzoi, Simona Frau, Amedeo Pau, Gabriele Murineddu, Battistina Asproni & Gerard A. Pinna. (2014) Tricyclic pyrazoles. Part 6. Benzofuro[3,2-c]pyrazole: A versatile architecture for CB2 selective ligands. European Journal of Medicinal Chemistry 82, pages 281-292.
Crossref
Crossref
Monika Gaba, Sarbjot Singh & Chander Mohan. (2014) Benzimidazole: An emerging scaffold for analgesic and?anti-inflammatory agents. European Journal of Medicinal Chemistry 76, pages 494-505.
Crossref
Crossref
Rodrigo Teodoro, Rareş-Petru Moldovan, Corinna Lueg, Robert Günther, Cornelius K Donat, Friedrich-Alexander Ludwig, Steffen Fischer, Winnie Deuther-Conrad, Bernhard Wünsch & Peter Brust. (2013) Radiofluorination and biological evaluation of N-aryl-oxadiazolyl-propionamides as potential radioligands for PET imaging of cannabinoid CB2 receptors. Organic and Medicinal Chemistry Letters 3:1.
Crossref
Crossref
Zhongwen Gao, Qingsan Zhu, Yiping Zhang, Yingzheng Zhao, Lu Cai, Christopher B. Shields & Jun Cai. (2013) Reciprocal Modulation Between Microglia and Astrocyte in Reactive Gliosis Following the CNS Injury. Molecular Neurobiology 48:3, pages 690-701.
Crossref
Crossref
GomesWardmanStockton Jr.Devi. (2013) Neuropeptide Receptors. Colloquium Series on Neuropeptides 2:1, pages 1-167.
Crossref
Crossref
Ken-ichi Kusakabe, Yukio Tada, Yasuyoshi Iso, Masahiro Sakagami, Yasuhide Morioka, Nobuo Chomei, Satomi Shinonome, Keiko Kawamoto, Hideyuki Takenaka, Kiyoshi Yasui, Hiroshi Hamana & Kohji Hanasaki. (2013) Design, synthesis, and binding mode prediction of 2-pyridone-based selective CB2 receptor agonists. Bioorganic & Medicinal Chemistry 21:7, pages 2045-2055.
Crossref
Crossref
R. M. Langford, J. Mares, A. Novotna, M. Vachova, I. Novakova, W. Notcutt & S. Ratcliffe. (2012) A double-blind, randomized, placebo-controlled, parallel-group study of THC/CBD oromucosal spray in combination with the existing treatment regimen, in the relief of central neuropathic pain in patients with multiple sclerosis. Journal of Neurology 260:4, pages 984-997.
Crossref
Crossref
JodiAnne T. Wood, Dustin M. Smith, David R. Janero, Alexander M. Zvonok & Alexandros Makriyannis. (2013) Therapeutic modulation of cannabinoid lipid signaling: Metabolic profiling of a novel antinociceptive cannabinoid-2 receptor agonist. Life Sciences 92:8-9, pages 482-491.
Crossref
Crossref
Mojgan Aghazadeh Tabrizi, Pier Giovanni Baraldi, Giulia Saponaro, Allan R. Moorman, Romeo Romagnoli, Delia Preti, Stefania Baraldi, Carmen Corciulo, Fabrizio Vincenzi, Pier Andrea Borea & Katia Varani. (2013)
Design, Synthesis, and Pharmacological Properties of New Heteroarylpyridine/Heteroarylpyrimidine Derivatives as CB
2
Cannabinoid Receptor Partial Agonists
. Journal of Medicinal Chemistry 56:3, pages 1098-1112.
Crossref
Crossref
Alleyn T. Plowright, Karolina Nilsson, Madeleine Antonsson, Kosrat Amin, Johan Broddefalk, Jörgen Jensen, Anders Lehmann, Shujuan Jin, Stephane St-Onge, Mirosław J. Tomaszewski, Maxime Tremblay, Christopher Walpole, Zhongyong Wei, Hua Yang & Johan Ulander. (2012) Discovery of Agonists of Cannabinoid Receptor 1 with Restricted Central Nervous System Penetration Aimed for Treatment of Gastroesophageal Reflux Disease. Journal of Medicinal Chemistry 56:1, pages 220-240.
Crossref
Crossref
Shane M. Wilkinson, Jason Price & Michael Kassiou. (2013) Improved accessibility to the desoxy analogues of ?9-tetrahydrocannabinol and cannabidiol. Tetrahedron Letters 54:1, pages 52-54.
Crossref
Crossref
Andrew J. Kwilasz & S. Stevens Negus. (2012)
Dissociable Effects of the Cannabinoid Receptor Agonists Δ
9
-Tetrahydrocannabinol and CP55940 on Pain-Stimulated Versus Pain-Depressed Behavior in Rats
. Journal of Pharmacology and Experimental Therapeutics 343:2, pages 389-400.
Crossref
Crossref
R. Russo, G. D’Agostino, G. Mattace Raso, C. Avagliano, C. Cristiano, R. Meli & A. Calignano. (2012) Central administration of oxytocin reduces hyperalgesia in mice: Implication for cannabinoid and opioid systems. Peptides 38:1, pages 81-88.
Crossref
Crossref
John P. Huggins, Trevor S. Smart, Stephen Langman, Louise Taylor & Tim Young. (2012) An efficient randomised, placebo-controlled clinical trial with the irreversible fatty acid amide hydrolase-1 inhibitor PF-04457845, which modulates endocannabinoids but fails to induce effective analgesia in patients with pain due to osteoarthritis of the knee. Pain 153:9, pages 1837-1846.
Crossref
Crossref
E. Ma Sánchez Robles, A. Bagües Arias & Ma I. Martín Fontelles. (2012) Cannabinoids and muscular pain. Effectiveness of the local administration in rat. European Journal of Pain 16:8, pages 1116-1127.
Crossref
Crossref
Brady K. Atwood, Alex Straiker & Ken Mackie. (2012) CB2: Therapeutic target-in-waiting. Progress in Neuro-Psychopharmacology and Biological Psychiatry 38:1, pages 16-20.
Crossref
Crossref
Zhushou Luo & Mohamed Naguib. (2012) A synthetic approach for (S)-(3-benzyl-3-methyl-2,3-dihydro-benzofuran-6-yl)-piperidin-1-yl-methanone, a selective CB2 receptor agonist. Tetrahedron Letters 53:26, pages 3316-3318.
Crossref
Crossref
Julia M. Adam, John K. Clark, Keneth Davies, Kathryn Everett, Ruth Fields, Stuart Francis, Fiona Jeremiah, Takao Kiyoi, Maurice Maidment, Angus Morrison, Paul Ratcliffe, Alan Prosser, Jurgen Schulz, Grant Wishart, James Baker, Susan Boyce, Robert Campbell, Jean E. Cottney, Maureen Deehan & Iain Martin. (2012) Low brain penetrant CB1 receptor agonists for the treatment of neuropathic pain. Bioorganic & Medicinal Chemistry Letters 22:8, pages 2932-2937.
Crossref
Crossref
Jose Cumella, Laura Hern?ndez-Folgado, Rocio Gir?n, Eva S?nchez, Paula Morales, Dow P. Hurst, Maria G?mez-Ca?as, Maria G?mez-Ruiz, Diana C. G. A. Pinto, Pilar Goya, Patricia H. Reggio, Mar?a Isabel Martin, Javier Fern?ndez-Ruiz, Artur M. S. Silva & Nadine Jagerovic. (2012)
Chromenopyrazoles: Non-psychoactive and Selective CB
1
Cannabinoid Agonists with Peripheral Antinociceptive Properties
. ChemMedChem 7:3, pages 452-463.
Crossref
Crossref
Yun-Xing Cheng, Mehrnaz Pourashraf, Xuehong Luo, Sanjay Srivastava, Christopher Walpole, Dominic Salois, Stephane St-Onge, Kemal Payza, Etienne Lessard, Xiao Hong Yu & Mirosław J. Tomaszewski. (2012) γ-Carbolines: A novel class of cannabinoid agonists with high aqueous solubility and restricted CNS penetration. Bioorganic & Medicinal Chemistry Letters 22:4, pages 1619-1624.
Crossref
Crossref
Antoni R. Blaazer, Jos H.M. Lange, Martina A.W. van der Neut, Arie Mulder, Femke S. den Boon, Taco R. Werkman, Chris G. Kruse & Wytse J. Wadman. (2011) Novel indole and azaindole (pyrrolopyridine) cannabinoid (CB) receptor agonists: Design, synthesis, structure–activity relationships, physicochemical properties and biological activity. European Journal of Medicinal Chemistry 46:10, pages 5086-5098.
Crossref
Crossref
Natasha L. Grimsey, Catherine E. Goodfellow, Mike Dragunow & Michelle Glass. (2011) Cannabinoid receptor 2 undergoes Rab5-mediated internalization and recycles via a Rab11-dependent pathway. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1813:8, pages 1554-1560.
Crossref
Crossref
Ren?e Zindell, Edward R. Walker, John Scott, Patricia Amouzegh, Lifen Wu, Monika Ermann, David Thomson, Micheal B. Fisher, Cody Lee Fullenwider, Heather Grbic, Paul Kaplita, Brian Linehan, Mita Patel, Monica Patel, Sabine L?bbe, Svenja Block, Claudia Albrecht, Mark J. Gemkow, Daw-Tsun Shih & Doris Riether. (2011) Aryl 1,4-diazepane compounds as potent and selective CB2 agonists: Optimization of drug-like properties and target independent parameters. Bioorganic & Medicinal Chemistry Letters 21:14, pages 4276-4280.
Crossref
Crossref
Gláucia Maria Lopes Reis, Marina Abadia Ramos, Daniela da Fonseca Pacheco, André Klein, Andréa Castro Perez & Igor Dimitri Gama Duarte. (2011) Endogenous cannabinoid receptor agonist anandamide induces peripheral antinociception by activation of ATP-sensitive K+ channels. Life Sciences 88:15-16, pages 653-657.
Crossref
Crossref
Doris Riether, Lifen Wu, Pier F. Cirillo, Angela Berry, Edward R. Walker, Monika Ermann, Beatriz Noya-Marino, James E. Jenkins, Dan Albaugh, Claudia Albrecht, Michael Fisher, Mark J. Gemkow, Heather Grbic, Sabine L?bbe, Clemens M?ller, Kathy O?Shea, Achim Sauer, Daw-Tsun Shih & David S. Thomson. (2011) 1,4-Diazepane compounds as potent and selective CB2 agonists: Optimization of metabolic stability. Bioorganic & Medicinal Chemistry Letters 21:7, pages 2011-2016.
Crossref
Crossref
Shu-Wei Yang, Jennifer Smotryski, Julius Matasi, Ginny Ho, Deen Tulshian, William J. Greenlee, Rossella Brusa, Massimiliano Beltramo & Kathleen Cox. (2011) Structure?activity relationships of 2,4-diphenyl-1H-imidazole analogs as CB2 receptor agonists for the treatment of chronic pain. Bioorganic & Medicinal Chemistry Letters 21:1, pages 182-185.
Crossref
Crossref
Sarah Geiger, Kathrin Nickl, Erich H. Schneider, Roland Seifert & Jörg Heilmann. (2010) Establishment of recombinant cannabinoid receptor assays and characterization of several natural and synthetic ligands. Naunyn-Schmiedeberg's Archives of Pharmacology 382:2, pages 177-191.
Crossref
Crossref
Divyanshoo R. Kohli, Yunfang Li, Sergey G. KhasabovPankaj GuptaLois J. KehlMarna E. Ericson, Julia Nguyen, Vinita Gupta, Robert P. Hebbel, Donald A. SimoneKalpna Gupta. (2010) Pain-related behaviors and neurochemical alterations in mice expressing sickle hemoglobin: modulation by cannabinoids. Blood 116:3, pages 456-465.
Crossref
Crossref
V Curto-Reyes, S Llames, A Hidalgo, L Menéndez & A Baamonde. (2010)
Spinal and peripheral analgesic effects of the CB
2
cannabinoid receptor agonist AM1241 in two models of bone cancer-induced pain
. British Journal of Pharmacology 160:3, pages 561-573.
Crossref
Crossref
L. Luongo, E. Palazzo, S. Tambaro, C. Giordano, L. Gatta, M.A. Scafuro, F.sca Rossi, P. Lazzari, L. Pani, V. de Novellis, M. Malcangio & S. Maione. (2010) 1-(2′,4′-dichlorophenyl)-6-methyl-N-cyclohexylamine-1,4-dihydroindeno[1,2-c]pyrazole-3-carboxamide, a novel CB2 agonist, alleviates neuropathic pain through functional microglial changes in mice. Neurobiology of Disease 37:1, pages 177-185.
Crossref
Crossref
Robert J. Gleave, Paul J. Beswick, Andrew J. Brown, Gerard M.P. Giblin, Paul Goldsmith, Carl P. Haslam, William L. Mitchell, Neville H. Nicholson, Lee W. Page, Sadhana Patel, Susan Roomans, Brian P. Slingsby & Martin E. Swarbrick. (2010) Synthesis and evaluation of 3-amino-6-aryl-pyridazines as selective CB2 agonists for the treatment of inflammatory pain. Bioorganic & Medicinal Chemistry Letters 20:2, pages 465-468.
Crossref
Crossref
Ian Sellitto, Bertrand Le Bourdonnec, Karin Worm, Allan Goodman, Markku A. Savolainen, Guo-Hua Chu, Christopher W. Ajello, Christopher T. Saeui, Lara K. Leister, Joel A. Cassel, Robert N. DeHaven, Christopher J. LaBuda, Michael Koblish, Patrick J. Little, Bernice L. Brogdon, Steven A. Smith & Roland E. Dolle. (2010) Novel sulfamoyl benzamides as selective CB2 agonists with improved in vitro metabolic stability. Bioorganic & Medicinal Chemistry Letters 20:1, pages 387-391.
Crossref
Crossref
Arno Hazekamp, Justin T. Fischedick, Mónica Llano Díez, Andrea Lubbe & Renee L. Ruhaak. 2010. Comprehensive Natural Products II. Comprehensive Natural Products II
1033
1084
.
Robert J. Gleave, Paul J. Beswick, Andrew J. Brown, Gerard M.P. Giblin, Carl P. Haslam, David Livermore, Andrew Moses, Neville H. Nicholson, Lee W. Page, Brian Slingsby & Martin E. Swarbrick. (2009) 2-Amino-5-aryl-pyridines as selective CB2 agonists: Synthesis and investigation of structure–activity relationships. Bioorganic & Medicinal Chemistry Letters 19:23, pages 6578-6581.
Crossref
Crossref
Anna Leichsenring, Michael Andriske, Ingo Bäcker, Christine C. Stichel & Hermann Lübbert. (2009) Analgesic and antiinflammatory effects of cannabinoid receptor agonists in a rat model of neuropathic pain. Naunyn-Schmiedeberg's Archives of Pharmacology 379:6, pages 627-636.
Crossref
Crossref
Volker Neugebauer, Vasco Galhardo, Sabatino Maione & Sean C. Mackey. (2009) Forebrain pain mechanisms. Brain Research Reviews 60:1, pages 226-242.
Crossref
Crossref
Ren?e Zindell, Doris Riether, Todd Bosanac, Angela Berry, Mark J. Gemkow, Andreas Ebneth, Sabine L?bbe, Ernest L. Raymond, Diane Thome, Daw-Tsun Shih & David Thomson. (2009) Morpholine containing CB2 selective agonists. Bioorganic & Medicinal Chemistry Letters 19:6, pages 1604-1609.
Crossref
Crossref
Lumír Ondřej Hanuš. (2008) Pharmacological and therapeutic secrets of plant and brain (endo)cannabinoids. Medicinal Research Reviews 29:2, pages 213-271.
Crossref
Crossref
S. McGaraughty, K.L. Chu, M.J. Dart, B.B. Yao & M.D. Meyer. (2009) A CB2 receptor agonist, A-836339, modulates wide dynamic range neuronal activity in neuropathic rats: Contributions of spinal and peripheral CB2 receptors. Neuroscience 158:4, pages 1652-1661.
Crossref
Crossref
Debra Mcguinness, Asra Malikzay, Richard Visconti, Karen Lin, Marvin Bayne, Frederick Monsma & Charles A. Lunn. (2008)
Characterizing Cannabinoid CB
2
Receptor Ligands Using DiscoveRx PathHunter™ β-Arrestin Assay
. Journal of Biomolecular Screening 14:1, pages 49-58.
Crossref
Crossref
John Malysz, Anthony V. Daza, Karen Kage, George K. Grayson, Betty B. Yao, Michael D. Meyer & Murali Gopalakrishnan. (2009) Characterization of human cannabinoid CB2 receptor coupled to chimeric G?qi5 and G?qo5 proteins. European Journal of Pharmacology 603:1-3, pages 12-21.
Crossref
Crossref
Isaac E. Marx, Erin F. DiMauro, Alan Cheng, Renee Emkey, Stephen A. Hitchcock, Liyue Huang, Ming Y. Huang, Jason Human, Josie H. Lee, Xingwen Li, Matthew W. Martin, Ryan D. White, Robert T. FremeauJr.Jr. & Vinod F. Patel. (2009) Discovery of ?-amidosulfones as potent and selective agonists of CB2: Synthesis, SAR, and pharmacokinetic properties. Bioorganic & Medicinal Chemistry Letters 19:1, pages 31-35.
Crossref
Crossref
Christian SinningBernhard WatzerOvidiu CosteRolf M. NüsingIngo OttAlessia LigrestiVincenzo Di MarzoPeter Imming. (2008)
New Analgesics Synthetically Derived from the Paracetamol Metabolite
N
-(4-Hydroxyphenyl)-(5
Z
,8
Z
,11
Z
,14
Z
)-icosatetra-5,8,11,14-enamide
. Journal of Medicinal Chemistry 51:24, pages 7800-7805.
Crossref
Crossref
I. A. Khasabova, S. G. Khasabov, C. Harding-Rose, L. G. Coicou, B. A. Seybold, A. E. Lindberg, C. D. Steevens, D. A. Simone & V. S. Seybold. (2008) A Decrease in Anandamide Signaling Contributes to the Maintenance of Cutaneous Mechanical Hyperalgesia in a Model of Bone Cancer Pain. Journal of Neuroscience 28:44, pages 11141-11152.
Crossref
Crossref
Yuan Cheng, Brian K. Albrecht, James Brown, John L. Buchanan, William H. Buckner, Erin F. DiMauro, Renee Emkey, Robert T. FremeauJr.Jr., Jean-Christophe Harmange, Beth J. Hoffman, Liyue Huang, Ming Huang, Josie Han Lee, Fen-Fen Lin, Matthew W. Martin, Hung Q. Nguyen, Vinod F. Patel, Susan A. Tomlinson, Ryan D. White, Xiaoyang Xia & Stephen A. Hitchcock. (2008)
Discovery and Optimization of a Novel Series of
N
-Arylamide Oxadiazoles as Potent, Highly Selective and Orally Bioavailable Cannabinoid Receptor 2 (CB
2
) Agonists
. Journal of Medicinal Chemistry 51:16, pages 5019-5034.
Crossref
Crossref
Erin F. DiMauro, John L. Buchanan, Alan Cheng, Renee Emkey, Stephen A. Hitchcock, Liyue Huang, Ming Y. Huang, Brett Janosky, Josie H. Lee, Xingwen Li, Matthew W. Martin, Susan A. Tomlinson, Ryan D. White, Xiao Mei Zheng, Vinod F. Patel & Robert T. FremeauJr.Jr.. (2008) Structural modifications of N-arylamide oxadiazoles: Identification of N-arylpiperidine oxadiazoles as potent and selective agonists of CB2. Bioorganic & Medicinal Chemistry Letters 18:15, pages 4267-4274.
Crossref
Crossref
Monika Ermann, Doris Riether, Edward R. Walker, Innocent F. Mushi, James E. Jenkins, Beatriz Noya-Marino, Mark L. Brewer, Malcolm G. Taylor, Patricia Amouzegh, Stephen P. East, Brian W. Dymock, Mark J. Gemkow, Andreas F. Kahrs, Andreas Ebneth, Sabine L?bbe, Kathy O?Shea, Daw-Tsun Shih & David Thomson. (2008) Arylsulfonamide CB2 receptor agonists: SAR and optimization of CB2 selectivity. Bioorganic & Medicinal Chemistry Letters 18:5, pages 1725-1729.
Crossref
Crossref
Andrea S. HeimannIvone GomesCamila S. DaleRosana L. PaganoAchla GuptaLaura L. de SouzaAugusto D. LuchessiLeandro M. Castro, Renata GiorgiVanessa Rioli, Emer S. Ferro & Lakshmi A. Devi. (2007)
Hemopressin is an inverse agonist of CB
1
cannabinoid receptors
. Proceedings of the National Academy of Sciences 104:51, pages 20588-20593.
Crossref
Crossref
Paul Cavuoto, Andrew J. McAinch, George Hatzinikolas, Alena Janovsk?Philip Game & Gary A. Wittert. (2007) The expression of receptors for endocannabinoids in human and rodent skeletal muscle. Biochemical and Biophysical Research Communications 364:1, pages 105-110.
Crossref
Crossref
A J Brown. (2007) Novel cannabinoid receptors. British Journal of Pharmacology 152:5, pages 567-575.
Crossref
Crossref